Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from gene editing

Forthcoming genetic therapies raise serious ethical questions, experts warn

One of greatest risks of gene editing tools ‘is that the people who would benefit most will not be able to access them’

The Guardian - UK · Mar 6, 2023

UK government urged to consider changing law to allow gene editing of embryos

Citizens’ panel of people with experience of genetic conditions says discussion urgently needed for research

The Guardian - UK · Mar 4, 2023

Does gene editing hold the key to improving mental health?

Research suggests traumatic childhood experiences embed themselves in our brains and put us at risk of mental illness, but epigenetic editing may offer us hope of removing them

The Guardian - UK · Feb 26, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

What is gene editing and how could it shape our future?

It is the most exciting time in genetics since the discovery of DNA in 1953. This is mainly due to scientific breakthroughs including the ability to change DNA through a process called gene editing.

The Conversation · Feb 14, 2023

In-vitro plant gene editing technique excluded from GMO rules, EU court says

In-vitro plant gene editing techniques that are used conventionally and have a long safety record are excluded from EU laws restricting the use of genetically modified organisms (GMOs), Europe's highest court said on Tuesday.

Reuters · Feb 7, 2023

How far should we go with gene editing in pursuit of the ‘perfect’ human?

As the world’s top human genome editing researchers gather in London, the ethical issues posed by pioneering scientific advances will be high on their agenda

The Guardian - UK · Feb 5, 2023

Gene editing company aims to bring dodo ‘back to life’

Scientists at US-based firm Colossal Biosciences believe they may successfully rebuild the dodo genome in the body of a living relative

Evening Standard · Feb 1, 2023

Read news from The Economist, FT, and more,
with one subscription

Gene editing company hopes to bring dodo ‘back to life’

Company is raising further $150m to pursue research on dodo which became extinct in 17th century

The Guardian - UK · Jan 31, 2023

The case of the first gene-edited babies

A new documentary looks at disgraced scientist He Jiankui, who helped create the first babies with edited genes

Salon · Dec 27, 2022

Did He Jiankui 'Make People Better'? Documentary spurs a new look at the case of the first gene-edited babies

In the four years since an experiment by disgraced scientist He Jiankui resulted in the birth of the first babies with edited genes, numerous articles, books and international commissions have reflected on whether and how heritable genome editing – that is, modifying genes that will be passed on to the…

The Conversation · Dec 20, 2022

Scotland should embrace UK moves on gene-editing science, says Alister Jack

ALISTER Jack has used a visit to a farming tech centre to reiterate calls for Scotland to embrace controversial gene-editing science – despite…

The National (Scotland) · Aug 15, 2022

Intellia's Gene-Editing Candidate Shows Durability In ATTR Amyloidosis

Intellia Therapeutics Inc (NASDAQ:NTLA) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced additional interim data from the Phase 1 study of NTLA-2001, in vivo genome editing candidate for transthyretin (ATTR) amyloidosis. Intellia had said that at the highest dose level (1.0mg/kg), six patients had shown a 93% mean reduction in the toxic protein. In the new data,…

Benzinga · Jun 24, 2022

The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Jun 22, 2022

BMO Capital Sees Over 400% Upside For This Small Gene-Editing Stock

BMO Capital Markets initiated coverage on Graphite Bio Inc (NASDAQ:GRPH), with a price target of $12 and an Outperform rating. The analyst notes that Graphite's gene editing approach involves a DNA repair mechanism that is known to be less vulnerable to errors. BMO writes that Graphite's platform is expected to be safer than existing…

Benzinga · Jun 17, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

The National (Scotland) · Jun 11, 2022

Gene-editing bill should not ‘force products on Scotland’, says minister

A BILL that would ease regulations around gene editing in the food sector should not “force products on Scotland”, a minister has said.

The National (Scotland) · May 29, 2022

Food experts slam BBC for 'repeating Tory lies’ on genetic edited foods

THE BBC and other media have been accused of “repeating uncritically and ad nauseam” UK Government “lies” about genetically edited foods.

The Guardian - UK · May 27, 2022

Britain is paving the way for gene-edited food – will the public stomach it?

Twenty years ago, the anti-GM movement had wide backing. Experts say the current mood on gene editing is softer

The Guardian - UK · May 24, 2022

Gene editing could increase food security, UK adviser says

Legislation introduced in House of Lords aims to help speed up development of gene-edited products

Get all your
news in one place.

100's of premium titles.
One news app.

Reason · May 21, 2022

Britain Finally Relaxes GMO Rules, but Advocates Want More Deregulation

New GMO rules are a good break from the E.U., but they don't go far enough.

The Independent UK · May 10, 2022

Queen’s Speech: Gene editing of animals and plants to get green light

Bill to relax regulations part of plan to ditch EU rules after Brexit

1 2 3 4

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Regeneron Pharmaceuticals Inc

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.